{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:40:23Z","timestamp":1732794023474,"version":"3.29.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00399-024-01047-5","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T10:02:13Z","timestamp":1731492133000},"page":"274-281","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiarrhythmika werden zuk\u00fcnftig keine Bedeutung in der Therapie des Vorhofflimmerns mehr haben","Antiarrhythmic drugs will no longer be of importance in the treatment of atrial fibrillation in the future"],"prefix":"10.1007","volume":"35","author":[{"given":"Andreas","family":"Metzner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanze","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"30","key":"1047_CR1","doi-asserted-by":"publisher","first-page":"ehae176","DOI":"10.1093\/eurheartj\/ehae176","volume":"2024","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder\u00a0IC, Rienstra\u00a0M, Bunting\u00a0KV, Casado-Arroyo\u00a0R, Caso\u00a0V, Crijns\u00a0HJGM, De Potter\u00a0TJR, Dwight\u00a0J, Guasti\u00a0L, Hanke\u00a0T, Jaarsma\u00a0T, Lettino\u00a0M, L\u00f8chen\u00a0ML, Lumbers\u00a0RT, Maesen\u00a0B, M\u00f8lgaard\u00a0I, Rosano\u00a0GMC, Sanders\u00a0P, Schnabel\u00a0RB, Suwalski\u00a0P, Svennberg\u00a0E, Tamargo\u00a0J, Tica\u00a0O, Traykov\u00a0V, Tzeis\u00a0S, Kotecha\u00a0D, ESC Scientific Document Group. (2024) ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart\u00a0J 2024(30):ehae176. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"issue":"12","key":"1047_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","volume":"43","author":"S Willems","year":"2022","unstructured":"Willems\u00a0S, Borof\u00a0K, Brandes\u00a0A, Breithardt\u00a0G, Camm\u00a0AJ, Crijns\u00a0HJGM, Eckardt\u00a0L, Gessler\u00a0N, Goette\u00a0A, Haegeli\u00a0LM, Heidbuchel\u00a0H, Kautzner\u00a0J, Ng\u00a0GA, Schnabel\u00a0RB, Suling\u00a0A, Szumowski\u00a0L, Themistoclakis\u00a0S, Vardas\u00a0P, van Gelder\u00a0IC, Wegscheider\u00a0K, Kirchhof\u00a0P (2022) Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4\u00a0trial. Eur Heart\u00a0J 43(12):1219\u20131230","journal-title":"Eur Heart J"},{"issue":"5","key":"1047_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C, Boriani\u00a0G, Castella\u00a0M, Dan\u00a0GA, Dilaveris\u00a0PE, Fauchier\u00a0L, Filippatos\u00a0G, Kalman\u00a0JM, La Meir\u00a0M, Lane\u00a0DA, Lebeau\u00a0JP, Lettino\u00a0M, Lip\u00a0GYH, Pinto\u00a0FJ, Thomas\u00a0GN, Valgimigli\u00a0M, Van Gelder\u00a0IC, Van Putte\u00a0BP, Watkins\u00a0CL, ESC Scientific Document Group (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart\u00a0J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"13","key":"1047_CR4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer\u00a0DL, Mark\u00a0DB, Robb\u00a0RA, Monahan\u00a0KH, Bahnson\u00a0TD, Poole\u00a0JE, Noseworthy\u00a0PA, Rosenberg\u00a0YD, Jeffries\u00a0N, Mitchell\u00a0LB, Flaker\u00a0GC, Pokushalov\u00a0E, Romanov\u00a0A, Bunch\u00a0TJ, Noelker\u00a0G, Ardashev\u00a0A, Revishvili\u00a0A, Wilber\u00a0DJ, Cappato\u00a0R, Kuck\u00a0KH, Hindricks\u00a0G, Davies\u00a0DW, Kowey\u00a0PR, Naccarelli\u00a0GV, Reiffel\u00a0JA, Piccini\u00a0JP, Silverstein\u00a0AP, Al-Khalidi\u00a0HR, Lee\u00a0KL, CABANA Investigators. (2019) Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA 321(13):1261\u20131274","journal-title":"JAMA"},{"issue":"4","key":"1047_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2029554","volume":"384","author":"OM Wazni","year":"2021","unstructured":"Wazni\u00a0OM, Dandamudi\u00a0G, Sood\u00a0N, Hoyt\u00a0R, Tyler\u00a0J, Durrani\u00a0S, Niebauer\u00a0M, Makati\u00a0K, Halperin\u00a0B, Gauri\u00a0A, Morales\u00a0G, Shao\u00a0M, Cerkvenik\u00a0J, Kaplon\u00a0RE, Nissen\u00a0SE, STOP AF First Trial Investigators. (2021) Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. N\u00a0Engl J Med 384(4):316\u2013324","journal-title":"N Engl J Med"},{"issue":"4","key":"1047_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","volume":"384","author":"JG Andrade","year":"2021","unstructured":"Andrade\u00a0JG, Wells\u00a0GA, Deyell\u00a0MW, Bennett\u00a0M, Essebag\u00a0V, Champagne\u00a0J, Roux\u00a0JF, Yung\u00a0D, Skanes\u00a0A, Khaykin\u00a0Y, Morillo\u00a0C, Jolly\u00a0U, Novak\u00a0P, Lockwood\u00a0E, Amit\u00a0G, Angaran\u00a0P, Sapp\u00a0J, Wardell\u00a0S, Lauck\u00a0S, Macle\u00a0L, Verma\u00a0A, EARLY-AF Investigators. (2021) Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N\u00a0Engl J Med 384(4):305\u2013315","journal-title":"N Engl J Med"},{"issue":"7","key":"1047_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/europace\/euab029","volume":"23","author":"M Kuniss","year":"2021","unstructured":"Kuniss\u00a0M, Pavlovic\u00a0N, Velagic\u00a0V, Hermida\u00a0JS, Healey\u00a0S, Arena\u00a0G, Badenco\u00a0N, Meyer\u00a0C, Chen\u00a0J, Iacopino\u00a0S, Anselme\u00a0F, Packer\u00a0DL, Pitschner\u00a0HF, Asmundis\u00a0C, Willems\u00a0S, Di Piazza\u00a0F, Becker\u00a0D, Chierchia\u00a0GB (2021) Cryo-FIRST Investigators. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace 23(7):1033\u20131041","journal-title":"Europace"},{"issue":"1","key":"1047_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.123.064959","volume":"148","author":"MK Turagam","year":"2023","unstructured":"Turagam\u00a0MK, Neuzil\u00a0P, Schmidt\u00a0B, Reichlin\u00a0T, Neven\u00a0K, Metzner\u00a0A, Hansen\u00a0J, Blaauw\u00a0Y, Maury\u00a0P, Arentz\u00a0T, Sommer\u00a0P, Anic\u00a0A, Anselme\u00a0F, Boveda\u00a0S, Deneke\u00a0T, Willems\u00a0S, van der Voort\u00a0P, Tilz\u00a0R, Funasako\u00a0M, Scherr\u00a0D, Wakili\u00a0R, Steven\u00a0D, Kautzner\u00a0J, Vijgen\u00a0J, Jais\u00a0P, Petru\u00a0J, Chun\u00a0J, Roten\u00a0L, F\u00fcting\u00a0A, Lemoine\u00a0MD, Ruwald\u00a0M, Mulder\u00a0BA, Rollin\u00a0A, Lehrmann\u00a0H, Fink\u00a0T, Jurisic\u00a0Z, Chaumont\u00a0C, Adeli\u00f1o\u00a0R, Nentwich\u00a0K, Gunawardene\u00a0M, Ouss\u00a0A, Heeger\u00a0CH, Manninger\u00a0M, Bohnen\u00a0JE, Sultan\u00a0A, Peichl\u00a0P, Koopman\u00a0P, Derval\u00a0N, Kueffer\u00a0T, Rahe\u00a0G, Reddy\u00a0VY (2023) Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes from the MANIFEST-PF Registry. Circulation 148(1):35\u201346","journal-title":"Circulation"},{"issue":"7","key":"1047_CR9","doi-asserted-by":"publisher","first-page":"euad185","DOI":"10.1093\/europace\/euad185","volume":"25","author":"B Schmidt","year":"2023","unstructured":"Schmidt\u00a0B, Bordignon\u00a0S, Neven\u00a0K, Reichlin\u00a0T, Blaauw\u00a0Y, Hansen\u00a0J, Adelino\u00a0R, Ouss\u00a0A, F\u00fcting\u00a0A, Roten\u00a0L, Mulder\u00a0BA, Ruwald\u00a0MH, Men\u00e9\u00a0R, van der Voort\u00a0P, Reinsch\u00a0N, Kueffer\u00a0T, Boveda\u00a0S, Albrecht\u00a0EM, Schneider\u00a0CW, Chun\u00a0KRJ (2023) EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace 25(7):euad185","journal-title":"Europace"},{"issue":"3","key":"1047_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","volume":"23","author":"KH Kuck","year":"2021","unstructured":"Kuck\u00a0KH, Lebedev\u00a0DS, Mikhaylov\u00a0EN, Romanov\u00a0A, Gell\u00e9r\u00a0L, Kal\u0113js\u00a0O, Neumann\u00a0T, Davtyan\u00a0K, On\u00a0YK, Popov\u00a0S, Bongiorni\u00a0MG, Schl\u00fcter\u00a0M, Willems\u00a0S, Ouyang\u00a0F (2021) Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace 23(3):362\u2013369","journal-title":"Europace"},{"issue":"2","key":"1047_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2212540","volume":"388","author":"JG Andrade","year":"2023","unstructured":"Andrade\u00a0JG, Deyell\u00a0MW, Macle\u00a0L, Wells\u00a0GA, Bennett\u00a0M, Essebag\u00a0V, Champagne\u00a0J, Roux\u00a0JF, Yung\u00a0D, Skanes\u00a0A, Khaykin\u00a0Y, Morillo\u00a0C, Jolly\u00a0U, Novak\u00a0P, Lockwood\u00a0E, Amit\u00a0G, Angaran\u00a0P, Sapp\u00a0J, Wardell\u00a0S, Lauck\u00a0S, Cadrin-Tourigny\u00a0J, Kochh\u00e4user\u00a0S, Verma\u00a0A, EARLYAF Investigators. (2023) Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. N\u00a0Engl J Med 388(2):105\u2013116","journal-title":"N Engl J Med"},{"issue":"5","key":"1047_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","volume":"36","author":"BA Steinberg","year":"2015","unstructured":"Steinberg\u00a0BA, Hellkamp\u00a0AS, Lokhnygina\u00a0Y, Patel\u00a0MR, Breithardt\u00a0G, Hankey\u00a0GJ, Becker\u00a0RC, Singer\u00a0DE, Halperin\u00a0JL, Hacke\u00a0W, Nessel\u00a0CC, Berkowitz\u00a0SD, Mahaffey\u00a0KW, Fox\u00a0KA, Califf\u00a0RM, Piccini\u00a0JP, ROCKET-AF Steering Committee and Investigators. (2015) Higher risk of death and stroke in patients with persistent vs. par-oxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart\u00a0J 36(5):288\u2013296","journal-title":"Eur Heart J"},{"issue":"5","key":"1047_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF, Brachmann\u00a0J, Andresen\u00a0D, Siebels\u00a0J, Boersma\u00a0L, Jordaens\u00a0L, Merkely\u00a0B, Pokushalov\u00a0E, Sanders\u00a0P, Proff\u00a0J, Schunkert\u00a0H, Christ\u00a0H, Vogt\u00a0J, B\u00e4nsch\u00a0D, CASTLE-AF Investigators. (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. N\u00a0Engl J Med 378(5):417\u2013427","journal-title":"N Engl J Med"},{"issue":"15","key":"1047_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","volume":"389","author":"C Sohns","year":"2023","unstructured":"Sohns\u00a0C, Fox\u00a0H, Marrouche\u00a0NF, Crijns\u00a0HJGM, Costard-Jaeckle\u00a0A, Bergau\u00a0L, Hindricks\u00a0G, Dagres\u00a0N, Sossalla\u00a0S, Schramm\u00a0R, Fink\u00a0T, El Hamriti\u00a0M, Moersdorf\u00a0M, Sciacca\u00a0V, Konietschke\u00a0F, Rudolph\u00a0V, Gummert\u00a0J, Tijssen\u00a0JGP, Sommer\u00a0P, CASTLE HTx Investigators. (2023) Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. N\u00a0Engl J Med 389(15):1380\u20131389","journal-title":"N Engl J Med"},{"issue":"4","key":"1047_CR15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/europace\/euab200","volume":"24","author":"A Metzner","year":"2022","unstructured":"Metzner\u00a0A, Suling\u00a0A, Brandes\u00a0A, Breithardt\u00a0G, Camm\u00a0AJ, Crijns\u00a0HJGM, Eckardt\u00a0L, Elvan\u00a0A, Goette\u00a0A, Haegeli\u00a0LM, Heidbuchel\u00a0H, Kautzner\u00a0J, Kuck\u00a0KH, Mont\u00a0L, Ng\u00a0GA, Szumowski\u00a0L, Themistoclakis\u00a0S, van Gelder\u00a0IC, Vardas\u00a0P, Wegscheider\u00a0K, Willems\u00a0S, Kirchhof\u00a0P (2022) Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a\u00a0detailed analysis of treatment patterns in the EAST\u2014AFNET 4\u00a0trial. Europace 24(4):552\u2013564","journal-title":"Europace"},{"issue":"18","key":"1047_CR16","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy\u00a0VY, Gerstenfeld\u00a0EP, Natale\u00a0A, Whang\u00a0W, Cuoco\u00a0FA, Patel\u00a0C, Mountantonakis\u00a0SE, Gibson\u00a0DN, Harding\u00a0JD, Ellis\u00a0CR, Ellenbogen\u00a0KA, DeLurgio\u00a0DB, Osorio\u00a0J, Achyutha\u00a0AB, Schneider\u00a0CW, Mugglin\u00a0AS, Albrecht\u00a0EM, Stein\u00a0KM, Lehmann\u00a0JW, Mansour\u00a0M, ADVENT Investigators. (2023) Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N\u00a0Engl J Med 389(18):1660\u20131671","journal-title":"N Engl J Med"},{"issue":"5","key":"1047_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41569-024-01004-2","volume":"21","author":"F Wiedmann","year":"2024","unstructured":"Wiedmann\u00a0F, Schmidt\u00a0C (2024) Novel drug therapies for atrial fibrillation. Nat Rev Cardiol 21(5):275\u2013276","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"1047_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMoa0803778","volume":"360","author":"SH Hohnloser","year":"2009","unstructured":"Hohnloser\u00a0SH, Crijns\u00a0HJ, van Eickels\u00a0M, Gaudin\u00a0C, Page\u00a0RL, Torp-Pedersen\u00a0C, Connolly\u00a0SJ, ATHENA Investigators. (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N\u00a0Engl J Med 360(7):668\u2013678","journal-title":"N Engl J Med"},{"issue":"11","key":"1047_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.amjcard.2010.07.037","volume":"106","author":"R Dabrowski","year":"2010","unstructured":"Dabrowski\u00a0R, Borowiec\u00a0A, Smolis-Bak\u00a0E, Kowalik\u00a0I, Sosnowski\u00a0C, Kraska\u00a0A, Kazimierska\u00a0B, Wozniak\u00a0J, Zareba\u00a0W, Szwed\u00a0H (2010) Effect of combined spironolactone-\u03b2-blocker\u00a0\u00b1 enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a\u00a0history of paroxysmal atrial fibrillation (SPIR-AF study). Am J Cardiol 106(11):1609\u20131614","journal-title":"Am J Cardiol"},{"issue":"6","key":"1047_CR20","doi-asserted-by":"publisher","first-page":"euae121","DOI":"10.1093\/europace\/euae121","volume":"26","author":"A Rillig","year":"2024","unstructured":"Rillig\u00a0A, Eckardt\u00a0L, Borof\u00a0K, Camm\u00a0AJ, Crijns\u00a0HJGM, Goette\u00a0A, Breithardt\u00a0G, Lemoine\u00a0MD, Metzner\u00a0A, Rottner\u00a0L, Schotten\u00a0U, Vettorazzi\u00a0E, Wegscheider\u00a0K, Zapf\u00a0A, Heidbuchel\u00a0H, Willems\u00a0S, Fabritz\u00a0L, Schnabel\u00a0RB, Magnussen\u00a0C, Kirchhof\u00a0P (2024) Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4\u00a0trial. Europace 26(6):euae121","journal-title":"Europace"},{"issue":"5","key":"1047_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/europace\/eux373","volume":"20","author":"GA Dan","year":"2018","unstructured":"Dan\u00a0GA, Martinez-Rubio\u00a0A, Agewall\u00a0S, Boriani\u00a0G, Borggrefe\u00a0M, Gaita\u00a0F, van Gelder\u00a0I, Gorenek\u00a0B, Kaski\u00a0JC, Kjeldsen\u00a0K, Lip\u00a0GYH, Merkely\u00a0B, Okumura\u00a0K, Piccini\u00a0JP, Potpara\u00a0T, Poulsen\u00a0BK, Saba\u00a0M, Savelieva\u00a0I, Tamargo\u00a0JL, Wolpert\u00a0C, ESC Scientific Document Group (2018) Antiarrhythmic drugs-clinical use and clinical decision making: a\u00a0consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace 20(5):731\u2013732a. https:\/\/doi.org\/10.1093\/europace\/eux373","journal-title":"Europace"},{"key":"1047_CR22","doi-asserted-by":"publisher","first-page":"euae204","DOI":"10.1093\/europace\/euae204","volume":"30","author":"A Goette","year":"2024","unstructured":"Goette\u00a0A, Corradi\u00a0D, Dobrev\u00a0D, Aguinaga\u00a0L, Cabrera\u00a0JA, Chugh\u00a0SS, de Groot\u00a0JR, Soulat-Dufour\u00a0L, Fenelon\u00a0G, Hatem\u00a0SN, Jalife\u00a0J, Lin\u00a0YJ, Lip\u00a0GYH, Marcus\u00a0GM, Murray\u00a0KT, Pak\u00a0HN, Schotten\u00a0U, Takahashi\u00a0N, Yamaguchi\u00a0T, Zoghbi\u00a0WA, Nattel\u00a0S (2024) Atrial Cardiomyopathy Revisited\u2014Evolution of a\u00a0Concept. A\u00a0Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Association (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace 30:euae204. https:\/\/doi.org\/10.1093\/europace\/euae204","journal-title":"Europace"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-024-01047-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:07:57Z","timestamp":1732792077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-024-01047-5"}},"subtitle":["Pro und Contra","Pros and cons"],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1007\/s00399-024-01047-5","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"type":"print","value":"0938-7412"},{"type":"electronic","value":"1435-1544"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Metzner erh\u00e4lt Honorare und Reisekosten von Medtronic, Abbott, Boston Scientific, Atricure, Daiichi Sankyo, Haemonetics, Bristol Myers Squibb, Lifetech, Biosense Webster\/Johnson & Johnson, Bayer, Pfizer. C.\u00a0Schmidt erh\u00e4lt Honorare von Medtronic, Abbott, Bayer, Boston Scientific, B\u00f6hringer. C.S. erh\u00e4lt Forschungsmittel von B\u00f6hringer Ingelheim, Bayer, Medtronic sowie Abbott. C.S. hat folgende thematische Patentanmeldungen\/Patente: pharmakologische TASK1-Hemmung, Nanopartikel basierte Arrhythmiebehandlung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}